{
  "nctId": "NCT03175731",
  "briefTitle": "PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)",
  "officialTitle": "A Randomized Controlled Study on the Effects of PPIs on Gastroesophageal Variceal Bleeding in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)",
  "protocolDocument": {
    "nctId": "NCT03175731",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-12-29",
    "uploadDate": "2021-05-12T22:59",
    "size": 214892,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03175731/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 106,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-05-01",
    "completionDate": "2019-08-30",
    "primaryCompletionDate": "2019-08-30",
    "firstSubmitDate": "2017-05-25",
    "firstPostDate": "2017-06-05"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Clinical diagnosis of cirrhosis\n* GEVs was diagnosed by endoscopy\n\nExclusion Criteria:\n\n* Acute gastrointestinal bleeding need emergency surgery\n* Acid-related disease, such as peptic ulcer disease or gastroesophageal reflux diseases (GERD)\n* Hepatocellular carcinoma (HCC) or other malignant tumor\n* History of esophagus, stomach or liver surgery\n* Child-Pugh C and can't be improved to Child-Pugh A or B\n* Preparing to be pregnant, pregnant or breast feeding\n* Allergic to PPIs(proton pump inhibitors) or intolerable\n* Cannot provide informed consent",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Variceal Bleeding Events",
        "description": "The primary endpoint was variceal bleeding, which was defined as hematemesis or melena from endoscopically proven GEVs, in the absence of any other lesion that might explain the bleeding.",
        "timeFrame": "8 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Mortality",
        "description": "Prognosis of esophagogastric variceal bleeding.",
        "timeFrame": "8 weeks"
      },
      {
        "measure": "Adverse Eventsafter Endoscopic Therapy",
        "description": "Advers events caused by endoscopic therapy, including chest pain, dysphagia, fever and so on",
        "timeFrame": "8 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:12.778Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}